Wockhardt Limited
WOCKPHARMA
Pozycja w akcjach
#4555
Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical... Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical and biotech company, in India, the United States, the United Kingdom, Switzerland, Ireland, Russia, Europe, and internationally. It manufactures and trades pharmaceuticals, medicinal chemical, and botanical products, as well as chemicals and chemical products. The company also develops its flagship antibiotic, ZAYNICH zidebactam/cefepime, a novel beta lactam enhancer mechanism for the treatment of sepsis and hospital/ventilator associated pneumonia; FOVISCU, an antibiotic for gram-negative infections; MIQNAF nafithromycin, which targets azithromycin-resistant community respiratory pathogens; and ODRATE, a once-daily combination of ertapenem and zidebactam for resistant gram-negative infections through outpatient parenteral antimicrobial therapy. In addition, it develops and commercializes insulin analogs, glucagon-like peptide-1 agonists, and novel combination drug products; Biovac-B, a recombinant hepatitis-B vaccine; Wepox, a recombinant human erythropoietin; Wosulin, a recombinant human insulin; and Glaritus, a recombinant insulin glargine. Further, the company offers delivery devices for insulin, including Dispopen disposable pen and Mypen reusable pen. Wockhardt Limited was founded in 1967 and is headquartered in Mumbai, India.
Cena akcji
$20.75
Kapitalizacja rynkowa
$3.37B
Zmiana (1 dzień)
-1.38%
Zmiana (1 rok)
33.03%
Kraj
IN
Handel Wockhardt Limited (WOCKPHARMA)
Kategoria
Healthcare
Przychody dla Wockhardt Limited (WOCKPHARMA)
Przychody w Jun 2026 TTM: $393.32M
Według najnowszych raportów finansowych Wockhardt Limited, obecny przychód firmy (TTM) wynosi $393.32M. W roku 2024 firma osiągnęła przychód w wysokości $339.40M wzrost w porównaniu do przychodu z roku 2023, który wynosił $323.31M. Przychód to całkowita kwota dochodu generowana przez firmę ze sprzedaży towarów lub usług. W przeciwieństwie do zysku, nie są odliczane żadne koszty.
Historia przychodów firmy Wockhardt Limited od 2004 do 2026
Przychody na koniec każdego roku
| Rok | Przychody | Zmień |
|---|---|---|
| 2026 (TTM) | $393.32M | 10.84% |
| 2025 | $354.86M | 4.56% |
| 2024 | $339.40M | 4.97% |
| 2023 | $323.31M | -24.02% |
| 2022 | $425.51M | 15.02% |
| 2021 | $369.93M | -2.01% |
| 2020 | $377.51M | -26.48% |
| 2019 | $513.51M | -14.80% |
| 2018 | $602.74M | -1.45% |
| 2017 | $611.63M | -9.01% |
| 2016 | $672.19M | -6.41% |
| 2015 | $718.21M | -10.88% |
| 2014 | $805.87M | -22.17% |
| 2013 | $1.04B | 13.80% |
| 2012 | $909.89M | 8.10% |
| 2011 | $841.74M | -16.02% |
| 2010 | $1.00B | 35.33% |
| 2008 | $740.59M | 9.85% |
| 2007 | $674.18M | 72.85% |
| 2006 | $390.03M | 24.39% |
| 2005 | $313.56M | 9.96% |
| 2004 | $285.15M | 0.00% |
Przychody podobnych firm lub konkurentów
| Firma | Przychody | Różnica w przychodach | Kraj |
|---|---|---|---|
| $2.54B | 544.77% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| $830.81M | 111.23% |
US
|
|
| - | - |
IT
|
